Salvatore Emma Jr
PRESIDENT and CEO at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/
Filed with the SEC as Emma Salvatore Jr
- Sold, on record
- $94k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Aug 19, 2014
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/PRESIDENT and CEO
Sales by reason
0
Routine
0
Plan not stated
0
No plan
1
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Aug 19, 2014Unusual
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/
Sold 100% of their holdings
$94k13,000 shares at $7.21
1 of 1
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 2018 | Oct 31, 2018 | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | CEO/President | AwardedStock Option | 5,000 | $3.50 | $18k | 5,000 | SEC |
| Mar 23, 2018 | Mar 27, 2018 | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | CEO/President | AwardedStock Option | 25,000 | $3.81 | $95k | 25,000 | SEC |
| Dec 16, 2016 | Dec 20, 2016 | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | CEO/President | Bought | 1,400 | $3.70 | $5k | 25,010 | SEC |
| Nov 30, 2016 | Dec 2, 2016 | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | CEO/President | AwardedStock Option | 25,000 | $4.02 | $100k | 25,000 | SEC |
| Mar 15, 2016 | Mar 17, 2016 | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | CEO/President | Bought | 2,500 | $3.92 | $10k | 23,610 | SEC |
| Dec 28, 2015 | Dec 31, 2015 | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | CEO/President/Director | Bought | 22,110 | $6.36 | $141k | 22,110 | SEC |
| Dec 28, 2015 | Dec 31, 2015 | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | CEO/President/Director | Returned to the companyStock Option | 1,000 | $3.41 | $3k | 0 | SEC |
| Jun 15, 2015 | Jun 16, 2015 | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | President and CEO | Bought | 1,100 | $6.50 | $7k | 21,110 | SEC |
| Jan 20, 2015 | Jan 22, 2015 | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | President and CEO | AwardedStock Option | 15,000 | $7.74 | $116k | 15,000 | SEC |
| Aug 19, 2014 | Aug 20, 2014 | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | PRESIDENT and CEO | Sold | 13,000 | $7.21 | $94k | 0 | SEC |
| Aug 19, 2014 | Aug 20, 2014 | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | PRESIDENT and CEO | Exercised or settledStock Option | 13,000 | $4.29 | $56k | 4,000 | SEC |
| Aug 19, 2014 | Aug 20, 2014 | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | PRESIDENT and CEO | Awarded | 13,000 | $4.29 | $56k | 13,000 | SEC |
Sales and notices (1)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2014 | Aug 20, 2014 | ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ | PRESIDENT and CEO | Form 4 sale | 13,000 | $94k | 100.0% | Unusual | SEC |